The fitness cost of mutations associated with human immunodeficiency virus type 1 drug resistance is modulated by mutational interactions

被引:104
作者
Cong, Mian-er [1 ]
Heneine, Walid [1 ]
Garcia-Lerma, J. Gerardo [1 ]
机构
[1] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA 30333 USA
关键词
D O I
10.1128/JVI.02712-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
It is generally accepted that the fitness cost of resistance mutations plays a role in the persistence of transmitted drug-resistant human immunodeficiency virus type I and that mutations that confer a high fitness cost are less able to persist in the absence of drug pressure. Here, we show that the fitness cost of reverse transcriptase (RT) mutations can vary within a 72-fold range. We also demonstrate that the fitness cost of M184V and K70R can be decreased or enhanced by other resistance mutations such as D67N and K219Q. We conclude that the persistence of transmitted RT mutants might range widely on the basis of fitness and that the modulation of fitness cost by mutational interactions will be a critical determinant of persistence.
引用
收藏
页码:3037 / 3041
页数:5
相关论文
共 25 条
[1]   Persistence of primary drug resistance among recently HIV-1 infected adults [J].
Barbour, JD ;
Hecht, FA ;
Wrin, T ;
Liegler, TJ ;
Ramstead, CA ;
Busch, MP ;
Segal, MR ;
Petropoulos, CJ ;
Grant, RM .
AIDS, 2004, 18 (12) :1683-1689
[2]   Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection [J].
Brenner, BG ;
Routy, JP ;
Petrella, M ;
Moisi, D ;
Oliveira, M ;
Detorio, M ;
Spira, B ;
Essabag, V ;
Conway, B ;
Lalonde, R ;
Sekaly, RP ;
Wainberg, MA .
JOURNAL OF VIROLOGY, 2002, 76 (04) :1753-1761
[3]   Stability of transmitted drug-resistant HIV-1 species [J].
Cane, PA .
CURRENT OPINION IN INFECTIOUS DISEASES, 2005, 18 (06) :537-542
[4]   Competitive fitness of nevirapine-resistant human immunodeficiency virus type 1 mutants [J].
Collins, JA ;
Thompson, MG ;
Paintsil, E ;
Ricketts, M ;
Gedzior, J ;
Alexander, L .
JOURNAL OF VIROLOGY, 2004, 78 (02) :603-611
[5]   Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus [J].
de Ronde, A ;
van Dooren, M ;
van der Hoek, L ;
Bouwhuis, D ;
de Rooij, E ;
van Gemen, B ;
de Boer, R ;
Goudsmit, J .
JOURNAL OF VIROLOGY, 2001, 75 (02) :595-602
[6]  
Delaugerre C, 2004, ANTIVIR THER, V9, P415
[7]   RNA virus mutations and fitness for survival [J].
Domingo, E ;
Holland, JJ .
ANNUAL REVIEW OF MICROBIOLOGY, 1997, 51 :151-178
[8]   Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus [J].
Gandhi, RT ;
Wurcel, A ;
Rosenberg, ES ;
Johnston, MN ;
Hellmann, N ;
Bates, M ;
Hirsch, MS ;
Walker, BD .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (12) :1693-1698
[9]   Diversity of thymidine analogue resistance genotypes among newly diagnosed HIV-1-infected persons [J].
García-Lerma, JG .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (02) :265-269
[10]   Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine [J].
García-Lerma, JG ;
MacInnes, H ;
Bennett, D ;
Weinstock, H ;
Heneine, W .
JOURNAL OF VIROLOGY, 2004, 78 (14) :7545-7552